|
|
Thomson Financial Business Description:
| The Group's principal activity is to discover, develop and market pharmaceutical products to prevent and treat diseases. The Group is developing a portfolio of vaccines against viral and bacterial diseases, including single-dose oral vaccines aimed at protecting travelers and people in endemic regions from cholera, typhoid fever and other illnesses. The Group's current collaborations encompass the development of an oral human rotavirus vaccine, vaccines to combat threats of biological warfare and vaccines addressing human food safety and animal health. In addition, the Group is conducting clinical studies of a proprietary vaccine candidate for cholesterol management. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Celldex Therapeutics, Inc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
